노을
376930KOSDAQ49.5 / 100
Reference Date: 2026-10-23
Company InformationBased on 2025 Annual Report
Business Overview
Noul is a company specializing in the development and sale of on-device AI solutions, 'miLab™', for blood and cancer diagnostics. By automating microscopic pathology processes and integrating AI-based diagnostic technology, miLab™ enables high-precision diagnostics even in environments lacking specialized personnel or infrastructure. The solution currently offers three applications—malaria diagnosis, peripheral blood smear analysis, and cervical cell analysis—and targets the mid-sized diagnostic lab market, where it holds a competitive advantage due to its offline capabilities and cost-effectiveness.
Number of Employees
130people
Average Salary
73.6M KRW
Score Calculation Basis
Detailed Financial Score
Half of industry avg (excellent)
Well below industry avg
Half of industry avg (excellent)
Avg ▲89.2% (2-year basis)
Avg ▼14.7% (2-year basis)
Avg ROE -72.7% (declining, 3yr)
Detailed News Sentiment
Detailed Momentum
52w lower range (37%)
1m -17.26% (strong drop)
Volume decreasing
Detailed Disclosure
- Neutral기타시장안내 (관리종목 지정사유 추가우려)(시가총액 200억원 미달)2026-10-14
